Delivery Order SPE2DB20D9354-SPE2DB23FX7R5

Award Date 6/1/23
Potential Completion Date 6/23/23
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This delivery order, awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., is for $15,904.35 to supply 1,000 mg/20 ml vials of Prolastin C. The firm fixed price contract has a period of performance through July 14, 2023. No set-aside designation was used for this procurement. The place of performance will be DMS Pharmaceutical's location in Park Ridge, Illinois. The Defense Logistics Agency manages the global supply chain for the United States military and supports...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $14,733.36 to DMS Pharmaceutical Group Inc. for the provision of 1,000 milligrams per 20 milliliters of Prolastin C. The place of performance will be DMS Pharmaceutical's facility located in Park Ridge, Illinois. The period of performance is scheduled to run from September 19, 2023 through October 11, 2023. No subcontractors or set aside designations were identified for this delivery order placed against an...
Defense Logistics Agency awarded DMS Pharmaceutical Group Inc. an $11,726 firm fixed price delivery order contract to supply 1,000 mg/20 ml vials of Prolastin C. The contract has a completion date of June 23, 2023 and was awarded on June 1, 2023. DMS Pharmaceutical Group Inc. will deliver the pharmaceutical products from its place of performance in Park Ridge, Illinois to the Defense Logistics Agency. No set-aside designation was used for this award to the prime contractor DMS Pharmaceutical...
The Defense Logistics Agency awarded a $14,774 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 1,000 mg/20 ml vials of PROLASTIN C. The place of performance will be DMS Pharmaceutical's facility located in Park Ridge, Illinois. The period of performance is from August 22, 2023 through September 13, 2023. The Defense Logistics Agency manages the Department of Defense's global supply chain and is responsible for procuring all medical supplies and pharmaceuticals needed...
The Defense Logistics Agency awarded a $15,233 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 1,000 mg/20 ml vials of PROLASTIN C. The place of performance will be DMS Pharmaceutical's facility located in Park Ridge, Illinois. The period of performance is July 11, 2023 through August 1, 2023. The Defense Logistics Agency manages the Department of Defense's global supply chain and is responsible for procuring pharmaceutical and medical supplies to support military...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at thirty-three thousand nine hundred ninety-four dollars and eighty cents ($33,994.80) to DMS Pharmaceutical Group Inc. to supply one thousand (1,000) milligrams per twenty (20) milliliters of Prolastin to support the Department of Defense. Performance will occur in Park Ridge, Illinois over a four-week period concluding on September 19, 2023. The delivery order was issued against an unspecified agency-level...
The Defense Logistics Agency Troop Support Medical awarded a $12,740 firm fixed price delivery order to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for 1,000 milligrams per 20 milliliters of Prolastin C to be delivered to the prime contractor's facility by August 22, 2023. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency supports Department of Defense health care programs by procuring pharmaceuticals, medical supplies, and...
The Defense Logistics Agency awarded a $16,534 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 1,000 mg/20 ml vials of PROLASTIN C. The product will be delivered to a location in Park Ridge, Illinois between June 30 and July 24, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics network and supply chain, and this delivery order was issued to fulfill pharmaceutical needs under an existing indefinite-delivery/indefinite-quantity...
DMS Pharmaceutical Group Inc. was awarded an $11,792 firm fixed price delivery order against an unspecified government-wide acquisition contract by the Defense Logistics Agency to provide 1,000 mg/20 ml vials of Prolastin C. The contract has a period of performance through May 15, 2023 for delivery to a location in Park Ridge, Illinois. No set-aside provisions were applied to this award to supply the specified pharmaceutical product to the Defense Logistics Agency for its medical supply needs.
Defense Logistics Agency awarded DMS Pharmaceutical Group Inc. a firm fixed price delivery order for $14,528.16 to supply 1,000 mg/20 ml vials of Prolastin C. Performance will occur in Park Ridge, Illinois and be completed by December 13, 2023. This order was issued against DMS Pharmaceutical Group's indefinite delivery contract with Defense Logistics Agency to provide pharmaceuticals and medical supplies with a potential value of up to $5 million through December 2025. As a woman-owned small...
  • SPE2DB20D9354
    Indefinite Delivery Contract
  • SPE2DB20D9354-SPE2DB23FX7R5
    Delivery Order

This delivery order, awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., is for the delivery of 1,000 mg/20 ml vials of Prolastin C with a potential value of $16,093. The place of performance is Park Ridge, Illinois and all items are to be delivered by June 23, 2023. No set-aside provisions were applied to this firm fixed price order. As the Defense Logistics Agency is responsible for worldwide logistics support of the Department of Defense, this order is likely intended to supply medical treatment to military personnel and installations. DMS Pharmaceutical Group will fulfill the order requirements for this pharmaceutical product to support the Defense Logistics Agency's mission.

Generated 1/2/24, 7:44 PM